Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) EPS (Basic) (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed EPS (Basic) for 8 consecutive years, with -$1.05 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 5.41% year-over-year to -$1.05, compared with a TTM value of -$2.4 through Dec 2025, up 20.27%, and an annual FY2025 reading of -$2.4, up 20.0% over the prior year.
  • EPS (Basic) was -$1.05 for Q4 2025 at Arcturus Therapeutics Holdings, down from -$0.49 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.44 in Q4 2022 and bottomed at -$2.15 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$0.7, with a median of -$0.91 recorded in 2022.
  • The sharpest move saw EPS (Basic) crashed 276.36% in 2021, then skyrocketed 402.04% in 2022.
  • Year by year, EPS (Basic) stood at -$1.47 in 2021, then surged by 402.04% to $4.44 in 2022, then tumbled by 109.91% to -$0.44 in 2023, then tumbled by 152.27% to -$1.11 in 2024, then rose by 5.41% to -$1.05 in 2025.
  • Business Quant data shows EPS (Basic) for ARCT at -$1.05 in Q4 2025, -$0.49 in Q3 2025, and -$0.34 in Q2 2025.